Our third entry of "Best of UEG Week 2024" is all about "bench to bedside" world-class science!
Interviewed by Julia Mayerle, Maria Del Pilar Acedo Nunez and Juozas Kupčinskas reflect on their highlights of the UEG Week 2024.
Sessions and abstracts mentioned:
Microbiota in diagnostics @03:35Microbiome: Bench to the future @03:35Pancreatic diseases: From mechanisms to therapy @04:05Session: IBD: Latest news on a personalised approach @05:25Session: Diagnose and treat to target in GI cancer: Latest news @05:25Pancreatic cancer: From bench to bedside @06:45FECAL MICROBIOTA TRANSPLANT VERSUS VANCOMYCIN FOR PRIMARY CLOSTRIDIODES DIFFICILE INFECTION – A RANDOMIZED NON-INFERIORITY TRIAL @08:50TARGETED FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS RECEIVING PEMBROLIZUMAB PLUS AXITINIB FOR METASTATIC RENAL CELL CARCINOMA: PRELIMINARY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (TACITO TRIAL) @09:05CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET @10:30Session: Understanding disease primers of IBD: Part 1Session: Understanding disease primers of IBD: Part 2Targeting kRAS in GI cancer @13:30SINGLE-NUCLEUS RNA SEQUENCING REVEALS THE CRUCIAL ROLE OF TERTIARY LYMPHOID STRUCTURES IN DRIVING B CELL MATURATION INTO PLASMA CELLS IN PDAC @14:30Never waste a good disaster: HPB @18:20